Safety, Tolerability, Pharmacokinetics of Intravenous RPX2003 (Biapenem) in Healthy Adult Subjects

Clinical trial NCT01702649 · COMPLETED

Trial details

NCT number: NCT01702649
Sponsor: Rempex Pharmaceuticals (a wholly owned subsidiary of The Medicines Company)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers Bacterial Infections

Start date: 2012-08-01
Primary completion: 2012-11-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.